Halozyme Therapeutics
HALO
#1814
Rank
A$17.07 B
Marketcap
A$149.77
Share price
0.06%
Change (1 day)
43.91%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2026 (TTM): A$0.85 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are A$1.66 Billion. In 2025 the company made an earning of A$0.67 Billion a decrease over its 2024 earnings that were of A$0.81 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.85 B25.67%
2025 A$0.67 B-16.2%
2024 A$0.81 B59.94%
2023 A$0.50 B39.94%
2022 A$0.36 B0.16%
2021 A$0.36 B92.2%
2020 A$0.18 B-278.96%
2019 -A$0.11 Billion-9.45%
2018 -A$0.12 Billion-229.51%
2017 A$89.6 M-160.48%
2016 -A$0.15 Billion216.03%
2015 -A$46.88 Million-52.86%
2014 -A$99.45 Million-18.09%
2013 -A$0.13 Billion55.88%
2012 -A$77.89 Million169.94%
2011 -A$28.86 Million-63.44%
2010 -A$78.92 Million-7.19%
2009 -A$85.03 Million15.91%
2008 -A$73.36 Million83.89%
2007 -A$39.89 Million78.1%
2006 -A$22.4 Million16%
2005 -A$19.31 Million45.24%
2004 -A$13.3 Million682.42%
2003 -A$1.7 Million1659.12%
2002 -A$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.22 B 3,109.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$10.13 B 1,094.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$50.56 B 5,860.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$11.32 B 1,235.08%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-A$0.28 Billion-132.06%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-A$70.77 Million-108.34%๐Ÿ‡บ๐Ÿ‡ธ USA